Evogene Ltd. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 0.578 million compared to USD 0.66 million a year ago. Net loss was USD 6.6 million compared to USD 3 million a year ago.

Basic loss per share from continuing operations was USD 0.13 compared to USD 0.07 a year ago.